Oneness Biotech Co., Ltd. (4743.TWO)
TWD 63.0
(-10.0%)
TWD 63.0
(-10.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 15.36 Billion TWD | -1.39% |
| 2022 | 15.58 Billion TWD | -0.96% |
| 2021 | 15.73 Billion TWD | 2.25% |
| 2020 | 15.38 Billion TWD | 120.42% |
| 2019 | 6.97 Billion TWD | 198.86% |
| 2018 | 2.33 Billion TWD | -7.38% |
| 2017 | 2.52 Billion TWD | -1.34% |
| 2016 | 2.55 Billion TWD | -8.96% |
| 2015 | 2.8 Billion TWD | 39.36% |
| 2014 | 2.01 Billion TWD | -3.61% |
| 2013 | 2.08 Billion TWD | 46.55% |
| 2012 | 1.42 Billion TWD | 2.8% |
| 2011 | 1.38 Billion TWD | 25.23% |
| 2010 | 1.1 Billion TWD | -0.49% |
| 2009 | 1.11 Billion TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 15.07 Billion TWD | -1.89% |
| 2024 Q2 | 14.75 Billion TWD | -2.1% |
| 2023 Q4 | 15.36 Billion TWD | 0.51% |
| 2023 FY | 15.36 Billion TWD | -1.39% |
| 2023 Q1 | 15.66 Billion TWD | 0.53% |
| 2023 Q2 | 15.45 Billion TWD | -1.32% |
| 2023 Q3 | 15.28 Billion TWD | -1.09% |
| 2022 Q1 | 15.92 Billion TWD | 1.23% |
| 2022 Q2 | 15.08 Billion TWD | -5.3% |
| 2022 Q3 | 16.27 Billion TWD | 7.94% |
| 2022 Q4 | 15.58 Billion TWD | -4.29% |
| 2022 FY | 15.58 Billion TWD | -0.96% |
| 2021 Q1 | 15.88 Billion TWD | 3.23% |
| 2021 FY | 15.73 Billion TWD | 2.25% |
| 2021 Q2 | 15.06 Billion TWD | -5.13% |
| 2021 Q3 | 14.62 Billion TWD | -2.96% |
| 2021 Q4 | 15.73 Billion TWD | 7.6% |
| 2020 Q4 | 15.38 Billion TWD | 40.43% |
| 2020 Q1 | 6.86 Billion TWD | -1.59% |
| 2020 Q2 | 10.53 Billion TWD | 53.33% |
| 2020 Q3 | 10.95 Billion TWD | 4.02% |
| 2020 FY | 15.38 Billion TWD | 120.42% |
| 2019 Q2 | 2.63 Billion TWD | -2.95% |
| 2019 FY | 6.97 Billion TWD | 198.86% |
| 2019 Q3 | 7.22 Billion TWD | 174.54% |
| 2019 Q1 | 2.71 Billion TWD | 16.12% |
| 2019 Q4 | 6.97 Billion TWD | -3.41% |
| 2018 Q1 | 2.43 Billion TWD | -3.49% |
| 2018 FY | 2.33 Billion TWD | -7.38% |
| 2018 Q4 | 2.33 Billion TWD | 6.25% |
| 2018 Q3 | 2.19 Billion TWD | -8.07% |
| 2018 Q2 | 2.39 Billion TWD | -1.75% |
| 2017 Q1 | 2.44 Billion TWD | -4.21% |
| 2017 Q3 | 2.55 Billion TWD | -0.19% |
| 2017 Q2 | 2.56 Billion TWD | 4.66% |
| 2017 Q4 | 2.52 Billion TWD | -1.41% |
| 2017 FY | 2.52 Billion TWD | -1.34% |
| 2016 FY | 2.55 Billion TWD | -8.96% |
| 2016 Q4 | 2.55 Billion TWD | -3.01% |
| 2016 Q3 | 2.63 Billion TWD | -0.88% |
| 2016 Q2 | 2.65 Billion TWD | -2.51% |
| 2016 Q1 | 2.72 Billion TWD | -2.86% |
| 2015 Q1 | 2.81 Billion TWD | 39.66% |
| 2015 FY | 2.8 Billion TWD | 39.36% |
| 2015 Q3 | 2.78 Billion TWD | 1.0% |
| 2015 Q4 | 2.8 Billion TWD | 0.85% |
| 2015 Q2 | 2.75 Billion TWD | -2.03% |
| 2014 Q2 | 2.24 Billion TWD | 5.47% |
| 2014 Q1 | 2.12 Billion TWD | 1.83% |
| 2014 FY | 2.01 Billion TWD | -3.61% |
| 2014 Q4 | 2.01 Billion TWD | -3.42% |
| 2014 Q3 | 2.08 Billion TWD | -7.08% |
| 2013 FY | 2.08 Billion TWD | 46.55% |
| 2013 Q4 | 2.08 Billion TWD | -4.18% |
| 2013 Q3 | 2.18 Billion TWD | 3.72% |
| 2013 Q2 | 2.1 Billion TWD | -1.7% |
| 2013 Q1 | 2.13 Billion TWD | 50.0% |
| 2012 Q4 | 1.42 Billion TWD | 2.33% |
| 2012 Q1 | 1.43 Billion TWD | 3.44% |
| 2012 Q2 | 1.39 Billion TWD | -2.68% |
| 2012 FY | 1.42 Billion TWD | 2.8% |
| 2012 Q3 | 1.39 Billion TWD | -0.2% |
| 2011 Q3 | 1.34 Billion TWD | 20.57% |
| 2011 Q4 | 1.38 Billion TWD | 3.39% |
| 2011 Q1 | 1.08 Billion TWD | -1.9% |
| 2011 Q2 | 1.11 Billion TWD | 2.42% |
| 2011 FY | 1.38 Billion TWD | 25.23% |
| 2010 FY | 1.1 Billion TWD | -0.49% |
| 2010 Q4 | 1.1 Billion TWD | 0.0% |
| 2009 FY | 1.11 Billion TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -11898.487% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | -429.62% |
| Level Biotechnology Inc. | 822.67 Million TWD | -1767.535% |
| Sagittarius Life Science Corp | 664.72 Million TWD | -2211.294% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | -2699.774% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | -294.556% |
| GlycoNex Incorporation | 1.55 Billion TWD | -889.41% |
| VBI | 452.1 Million TWD | -3298.282% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | -1206.28% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | -1952.404% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -3960.583% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | -1255.01% |
| Visgeneer Inc. | 397.17 Million TWD | -3768.235% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | -307.482% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | -611.601% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | -1639.757% |
| Neith Corporation | 192.15 Million TWD | -7895.557% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | -152.168% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -20786.515% |
| Enimmune corporation | 604.82 Million TWD | -2440.181% |
| TaiRx, Inc. | 833.74 Million TWD | -1742.732% |
| CHO Pharma, Inc. | 3.08 Billion TWD | -397.847% |
| EirGenix Inc. | 11.16 Billion TWD | -37.636% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -2580.624% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | -797.222% |
| Lin BioScience, Inc. | 3.59 Billion TWD | -327.158% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | -1362.54% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -5003.678% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -5705.138% |
| Lukas Biomedical Inc. | 441.19 Million TWD | -3382.325% |
| RBC Bioscience Corporation | 753.79 Million TWD | -1938.194% |
| BiOptic Inc. | 613.77 Million TWD | -2403.157% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | -763.774% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | -1224.783% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -2282.527% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | -394.606% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -10285.512% |
| NaviFUS Corp. | 490.53 Million TWD | -3032.03% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | -1153.447% |
| Sinew Pharma Inc. | 1.36 Billion TWD | -1026.888% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -2803.49% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | -1222.875% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | -827.604% |
| AP Biosciences Inc | 890.75 Million TWD | -1624.794% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | -80.172% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -4639.719% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | -1052.01% |
| Intech Biopharm Corporation | 2.71 Billion TWD | -466.703% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -3644.888% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -3771.403% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | -640.091% |
| TCI GENE Inc. | 1.16 Billion TWD | -1217.71% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -5115.443% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | -1026.924% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | -1531.38% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | -2099.682% |
| PharmaEngine, Inc. | 3.95 Billion TWD | -288.569% |
| Savior Lifetec Corporation | 3.82 Billion TWD | -301.91% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | -1149.246% |
| OBI Pharma, Inc. | 5.6 Billion TWD | -174.161% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | -1346.665% |
| Acepodia, Inc. | 6.81 Billion TWD | -125.323% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | -301.508% |